Milestone Pharmaceuticals Inc. Common Shares (MIST) Stock Price, Quote & AI Analysis

Live MIST stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Milestone Pharmaceuticals Inc. Common Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for Milestone Pharmaceuticals Inc. Common Shares (MIST), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

MIST
Milestone Pharmaceuticals Inc. Common Shares
real-time
$0.00 +0.00 (+0.00%)
Open
1.280000
High
1.280000
Low
1.210000
Volume
2,424,417
VWAP
-
Market Cap
$160,602,394.20
52W Range
$1.00 - $3.06
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Aug 10, 2026 Q2
Market
EPS Estimate: $-0.204
Revenue Estimate: $1,132,200.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Milestone Pharmaceuticals Inc. Common Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Milestone Pharmaceuticals Inc. Common Shares Overview

Company information

Company Overview

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, rapid ventricular rate, and other cardiovascular indications. The company was founded by Philippe Douville and Philippe Lamarre in 2003 and is headquartered in Montreal, Canada.

Company Details
Market Cap
$152.51M
Shares Outstanding
124,498,000
Weighted Shares Outstanding
124,497,980
CEO
Joseph G. Oliveto
Address
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, A8, H4M 2X6
Employees
38
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Milestone Pharmaceuticals Inc. Common Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...